Title of Collaborative Activity: |
NIH-FDA Joint Leadership Council |
Description of Collaborative Activity: |
The NIH-FDA Joint Leadership Council work together to help ensure that regulatory considerations form an integral component of biomedical research planning and the latest science is integrated into the regulatory review process. Such collaboration and integration will advance the development of new products for the treatment, diagnosis and prevention of common and rare diseases and enhance the safety, quality, and efficiency of the clinical research and medical product approval enterprise. The formation of the Leadership Council represents a commitment on the part of both agencies to forge a strong partnership and to leverage the strengths of each agency toward this common goal. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2010 |
NIH Participating Institutes/Centers/Office of the Director: |
NCATS, NCCIH, NCI, NHLBI, NIAID, NIDDK, NIMH, NINDS, OD/OSP |
HHS Agency Collaborators on this Activity: |
FDA |
